Moderna announces data from Phase 1 mRNA cancer vaccine study

The data revealed Moderna’s mRNA personalized cancer vaccine (PCV) mRNA-4157 to be well-tolerated at all tested doses and elicited neoantigen-specific T-cell responses. Massachusetts-based biotechnology firm, Moderna, Inc. has recen....

Novartis unveils positive Phase III trial data for asthma treatment

Novartis has recently unveiled the first clinical trial results from the phase III PLATINUM clinical development program evaluating the efficacy and safety of QMF149, which is an investigational, once a day, fixed dose combination treatment....

Mesoblast submits BLA for remestemcel-L to treat aGVHD in children

Mesoblast Limited has reportedly filed a rolling submission for Biologics License Application with the U.S Food and Drug Administration for remestemcel-L to treat steroid-refractory acute graft versus host disease in children. Sources clai....

Wayland Group declares completion of transaction with ICC International

The pro rata interest of ICC will not be raised in Wayland International by its contributions and developments. Canada-based Wayland Group has reportedly announced that it has closed a transaction relating to the sale of a 49.9 percent int....

Rexgenero expands manufacturing of cell-based CLI therapy REX-001

A regenerative medicine company Rexgenero, creating advanced cell-based therapies for the treatment of critical limb ischaemia, has reportedly expanded the production of its lead development therapy REX-001 by partnering with the German Red....

NetApp acquires data protection company Cognigo for $70 million

NetApp Inc., a U.S. hybrid cloud data services company has recently acquired Israeli data protection and compliance startup, Cognigo, for approximately $70 million. Following the acquisition, 35 of Cognigo’s employees will be joining ....

Sony withdraws its mobile phone business from Southeast Asia

The move comes under the company’s current strategy of redirecting its focus on Japan, Taiwan, Hong Kong, and Europe. The company expects to lower operating expenditure by almost 50% while reducing overall cost by 57% by 2020. So....

Trump claims Huawei issue could be resolved in US-China trade deal

The Trump government had effectively banned American companies from conducting business with the Chinese telecommunications equipment company. The President claimed that the complaints against Huawei might possibly by resolved in the U.S....

Eli Lilly’s mirikizumab scores positive data in Phase II Crohn’s study

The company plans to initiate Phase III trials to assess mirikizumab’s benefit-risk profile to cure Crohn’s disease. U.S. pharma giant, Eli Lilly and Co. has recently announced positive data from the Serenity Phase II study tha....

Merck to acquire cancer drug maker Peloton Therapeutics for $1.05Bn

The acquisition would help Merck strengthen its presence in the renal cell carcinoma space and support its cancer drug portfolio. U.S. pharmaceutical conglomerate, Merck & Co. Inc. has recently agreed to purchase Dallas based Peloton T....